Splanchnic Venous Thrombosis in Acute Pancreatitis: Does Anticoagulation Affect Outcome?
Gastroenterology Research · 2020 · 13 (1) · 25-31
DOI: 10.14740/gr1223 ↗At a glance
Journal article in Gastroenterology Research, 2020. Written by Parmeshwar Ramesh Junare and 8 co-authors. Institution: Department of Gastroenterology, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital,Mumbai, India. Cited 54 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
BACKGROUND: Splanchnic venous system thrombosis is a well recognized local vascular complication of acute pancreatitis (AP). It may involve thrombosis of splenic vein (SplV), portal vein (PV) and superior mesenteric vein (SMV), either separately or in combinations, and often detected incidentally, indeed some cases present with upper gastrointestinal bleed, bowel ischemia and hepatic decompensation. Incidence is variable depending on study subjects and diagnostic modalities. Pathogenesis is multifactorial centered on local and systemic inflammation. Management involves treatment of underlying AP and its complications. Universal use of anticoagulation may lead to increased risk of bleeding due to frequent need of interventions (radiologic/endoscopic/surgical). Literature on anticoagulation in setting of AP is sparse and at present there is no consensus guideline on it. Current article details our experience on splanchnic venous thrombosis (SVT) in AP in a well defined cohort of patients at a tertiary care center. METHODS: Hospitalized patients with AP from January 2018 to December 2018 were included in the study. Detailed information on demographic, clinical, laboratory, radiologic features, and indication of anticoagulation use were collected prospectively during the index admission. Outcome variables were analyzed at the end of 6 months. RESULTS: Twenty four out of 105 (22.85%) patients with AP develop SVT. Etiology of AP was alcohol use in 21/24 (87.5%) subjects. Most common vessel involved was isolated SplV in 11/24 (45.8%) patients followed by SplV along with PV and SMV 9/24 (37.50%, P 0.05 with respect to all above variables). CONCLUSIONS: SVT is commonly seen in alcohol-induced AP. Anticoagulation does not affect outcomes of SVT. Subset of patients may benefit with anticoagulation.
Subjects
Author keywords
Authors and institutions
- Department of Gastroenterology, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital,Mumbai, India.
- Department of Radio-Diagnosis, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital,Mumbai, India.
Cite
APA
Junare, P. R., Udgirkar, S., Nair, S., Debnath, P., Jain, S., Modi, A., Rathi, P., Rane, S., & Contractor, Q. (2020). Splanchnic Venous Thrombosis in Acute Pancreatitis: Does Anticoagulation Affect Outcome?. Gastroenterology Research, 13(1), 25-31. https://doi.org/10.14740/gr1223
Vancouver
Junare PR, Udgirkar S, Nair S, Debnath P, Jain S, Modi A, et al. Splanchnic Venous Thrombosis in Acute Pancreatitis: Does Anticoagulation Affect Outcome?. Gastroenterology Research. 2020;13(1):25-31. doi:10.14740/gr1223
BibTeX
@article{Junare2020,
author = {Junare, Parmeshwar Ramesh and Udgirkar, Suhas and Nair, Sujit and Debnath, Prasanta and Jain, Shubham and Modi, Ammar and Rathi, Pravin and Rane, Siddhesh and Contractor, Qais},
title = {Splanchnic Venous Thrombosis in Acute Pancreatitis: Does Anticoagulation Affect Outcome?},
journal = {Gastroenterology Research},
year = {2020},
volume = {13},
number = {1},
pages = {25--31},
doi = {10.14740/gr1223}
}
EUVIMED